Diligence memo · auto-generated · as of July 2, 2026
CHD Bioscience, Inc.
CHD Bioscience, Inc. has raised $19M over 8 rounds; too few niche peers to rank its valuation yet.
Businessfiled
CHD Bioscience, Inc. operates in Biotech, based in FORT COLLINS.
Sub-sector tags: biotech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
CHD Bioscience, Inc. has raised $19M in disclosed capital across 8 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $14M on 2017-07-01.
Most recent recorded round closed around 2025-06-27.
Valuation (modeled)modeled
Provath models CHD Bioscience, Inc. at approximately $3.3M (range $1.1M–$5.6M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 12 mo ago; this sector typically re-raises about every 11 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 5.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 89% of Biotech peers (233 compared).
Modeled value ranks above 72% of those peers.
Closest niche peers: Tamarind Bio, Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.